The ability to reprogram somatic cells to generate induced pluripotent stem (iPS) cells has generated tremendous interest and discussion since iPS cells were first produced from mouse cells in 2006 ...
The CiRA Foundation has published a paper in Med that provides an update on the iPS Cell Stock Project. The reprogramming of peripheral or cord blood from 7 donors who are homozygous for HLA-A, -B, ...
Hosted on MSN
Japan's iPS Cell Breakthroughs Are Reshaping Regenerative Medicine and Parkinson's Treatment
“It is a significant achievement that we have been able to confirm improvement in patients’ symptoms,” Director of Kyoto University’s Center for iPS Cell Research and Application (CiRA) Jun Takahashi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results